Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2023-11-15 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
112年11月法人說明會簡報 — 172020231115E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled '2023 Investor Conference 11/16/2023' and contains detailed financial data including consolidated income statements, balance sheets, cash flows for Q1-Q3 2023, and comparisons with previous years. It also includes forward-looking statements, future operation strategy, and corporate social responsibility information. The content is comprehensive and includes actual financial statements and analysis for a period shorter than a full fiscal year (Q1-Q3). This matches the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, which is substantial and contains the report itself, not just an announcement or a presentation. Therefore, the correct classification is IR with high confidence.
2023-11-15 Chinese
112年11月法人說明會簡報 — 172020231115M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation from Standard Chem & Pharm Co., Ltd. dated November 16, 2023, covering the company's business overview, 2023 first three quarters operational results, future strategies, and corporate social responsibility. It includes financial data such as consolidated income statements, balance sheets, cash flow statements, and EPS figures for the first three quarters of 2023, as well as historical quarterly revenue comparisons. The content is structured as a slide presentation with forward-looking statements and strategic outlook, typical of investor presentations. It is not a full annual or interim report, nor is it a brief earnings release or regulatory filing. The presence of detailed financial data and strategic discussion aligns with the definition of an Investor Presentation (IP). The document length is substantial (15,000 characters), and it contains substantive financial and strategic information rather than just an announcement or certification. Therefore, the appropriate classification is Investor Presentation (IP).
2023-11-15 Chinese
112年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about an upcoming or recent investor presentation (法人說明會) for company code 1720, including date, time, location, summary of the presentation content, and links to PDF presentation files and video streams. The content is clearly about an investor presentation event and related materials, not a full financial report or earnings release. The document length is short (1069 characters) and it provides links to presentation files rather than containing detailed financial data itself. Therefore, this document is best classified as an Investor Presentation (IP).
2023-11-15 Chinese
公告本公司召開法人說明會相關資訊
Investor Presentation Classification · 95% confidence The document is a short announcement (667 characters) from a company (1720 生達) about scheduling a '法人說明會' (investor presentation) on 112/11/16, including date, time, location, and a brief description that the presentation will cover the 2023 first three quarters operational overview. It also directs readers to the public information site for complete financial and business information. There is no actual financial data or detailed report content included, only an announcement of the event and where to find further information. According to the 'MENU VS MEAL' rule, this is an announcement of an investor presentation, not the presentation itself. Therefore, the correct classification is Investor Presentation (IP).
2023-11-13 Chinese
112年第3季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a tabular financial disclosure showing investment details in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. It references specific accounting standards for securities issuers' financial report preparation. The document length is short (1081 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication of it being an annual or interim report, audit report, or earnings release. It is also not a meeting-related document or a capital/financing update. Given the nature and format, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-11-13 Chinese
112年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment gains/losses, and regulatory approval limits. The document is relatively short (1516 characters) and does not appear to be a full financial report or an announcement of a report. It is a regulatory disclosure related to investment activities, but it does not fit the definitions of Annual Report, Interim Report, or other financial reports. It is a regulatory filing providing specific investment information as required by authorities, thus best classified under Regulatory Filings (RNS).
2023-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.